Medication info
Glipizide Tablet 25 mg (Sitagliptin Hydrochloride Hydrate)

Glipizide Tablet 25 mg (Sitagliptin Hydrochloride Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›28.34mg / 1 tablet
Manufacturer / importer
Kips Biopharma Co., Ltd.
Appearance
Bright yellow-orange round film-coated tablets
Packaging
100 tablets/bottle, 30 tablets/bottle
Approval status
Active

MFDS item code 202102830 · Approved 2021.03.31 · Insurance code 693202440

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dose adjustment according to renal function is required, evaluation of renal function is recommended before starting treatment with this medicine and periodically thereafter. 1. No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered without regard to the timing of dialysis.

Ingredients

Manufacturer
Kips Biopharma Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

  • Difficulty controlling blood sugar in patients with type 2 diabetes
View approved original text

This drug is used in conjunction with diet and exercise to help control blood sugar levels in patients with type 2 diabetes. It can be used alone or in combination with metformin in patients who are starting treatment and have difficulty controlling blood sugar with monotherapy. Additionally, it can be added when blood sugar control is inadequate with monotherapy or combination therapy using sulfonylureas, metformin, thiazolidinediones, or insulin. It is effective in improving blood sugar control through various combination therapies and monotherapies. Overall, this drug is used to improve blood sugar control in patients with type 2 diabetes.

How to take

Adult dose

Administer 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dose adjustment according to renal function is required, evaluation of renal function is recommended before starting treatment with this medicine and periodically thereafter. 1. No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered without regard to the timing of dialysis.

Precautions

This drug can rarely cause serious allergic reactions, so if symptoms such as rash or difficulty breathing occur, it should be discontinued immediately, and a doctor should be consulted. Acute pancreatitis may occur during the use of this drug, so if abdominal pain, vomiting, or severe abdominal pain occurs, medical personnel should be notified immediately. This drug should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and patients who are allergic to this drug or its components should also avoid its use. Patients with renal impairment need to adjust the dosage of this drug and should undergo regular renal function tests. Hypoglycemic symptoms may occur when this drug is used alone or in combination with other antidiabetic medications, so caution should be exercised when taken with medications that pose a risk of hypoglycemia, and adjustments to the dosages of other medications may be necessary. Symptoms such as headache, upper respiratory tract infection, nasopharyngitis, diarrhea may occur during the use of this drug, and if these symptoms persist or worsen, it is advisable to consult a doctor. If severe joint pain or blistering skin symptoms occur, the use of this drug should be discontinued immediately, and medical personnel should be consulted. It is recommended that women who are pregnant or breastfeeding do not take this drug, and the safety and efficacy in children under 18 have not been established. Elderly patients may require dosage adjustment and monitoring of renal function due to the potential for renal impairment. In cases of overdose, general emergency treatment can be applied and some medications can be removed through hemodialysis, so if overdose is suspected, medical institutions should be visited immediately.

Side effects

  • Anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • exfoliative skin disease
  • acute pancreatitis
  • hypoglycemia
  • nasopharyngitis
  • upper respiratory tract infection
  • headache
  • diarrhea
Show 29 more
  • abdominal pain
  • nausea
  • peripheral edema
  • constipation
  • vomiting
  • severe and debilitating arthralgia
  • blistering similar to pemphigus
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • pneumonia
  • diabetic complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased blood triglycerides
  • gastritis
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly closed container to prevent air and moisture from entering. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius to ensure the drug's efficacy and safety.

Appearance and packaging

Appearance

Bright yellow-orange round film-coated tablets

Package unit

100 tablets/bottle, 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.